FindTrial
Sign In

COMPARATIVE STUDY, DOUBLE BLIND, RANDOMIZED, PROSPECTIVE, MULTICENTRIC TO EVALUATE THE SAFETY, LOCAL TOLERABILITY AND CLINICAL RESULTS OF SODIUM ERTAPENEM (MK-0826) AGAINST SODIUM CEFTRIAXONE PATIENT INFLUENCED PEDIAT INFECTED PEDIAT INFLUENCED PEDIAT INFLUENCED PEDIAT INFLUENCED PEDIAT INFLATED PEDIAT INFECTION OR COMMUNITY ACQUIRED PNEUMONIA

COMPARATIVE STUDY, DOUBLE BLIND, RANDOMIZED, PROSPECTIVE, MULTICENTRIC TO EVALUATE THE SAFETY, LOCAL TOLERABILITY AND CLINICAL RESULTS OF SODIUM ERTAPENEM (MK-0826) AGAINST SODIUM CEFTRIAXONE PATIENT INFLUENCED PEDIAT INFECTED PEDIAT INFLUENCED PEDIAT INFLUENCED PEDIAT INFLUENCED PEDIAT INFLATED PEDIAT INFECTION OR COMMUNITY ACQUIRED PNEUMONIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-024-02
Enrollment
Unknown
Registered
2002-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

NA Type of group

Sponsors

MERCK SHARP & DOHME PERU S.R.L.,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: NA

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Outcome name:NA Measure:NA Timepoints:NA—

Secondary

MeasureTime frame
Outcome name:NA Measure:NA Timepoints:NA—

Outcome results

None listed

Source: REPEC (via WHO ICTRP)